首页> 美国卫生研究院文献>American Health Drug Benefits >Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting

【2h】

Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting

机译：肠胃外抗凝剂和华法林的利用：对门诊患者静脉血栓栓塞复发的风险的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundClinical guidelines recommend parenteral anticoagulation therapy with an early initiation of warfarin therapy for the treatment of patients with acute venous thromboembolism (VTE) and the prevention of recurrence.

机译：背景技术临床指南建议肠胃外抗凝疗法应尽早开始使用华法林疗法，以治疗急性静脉血栓栓塞症（VTE）和预防复发。

著录项

期刊名称 American Health Drug Benefits
作者
Jennifer Cai; Ronald Preblick; Qiaoyi Zhang; Winghan Jacqueline Kwong; James T. Kenney;
展开▼
作者单位

展开▼
年(卷),期 2014(7),8
年度 2014
页码 444–451
总页数 8
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism: [J] . Catherine A Saint, Michelle R Castelli, Andrew J Crannage, Sage Open Medicine . 2017,第2期

机译：非维生素K口服抗凝剂或肠胃外药物加华法林治疗静脉血栓栓塞患者的住院时间比较：
2. A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism. [J] . Monkman K, Lazo Langner A, Kovacs MJ Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2009,第3期

机译：在开始口服抗凝治疗静脉血栓栓塞的门诊患者中，10 mg华法林起始剂量诺模图是安全有效的。
3. Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis [J] . Neil A. Zakai, Rob F. Walker, Richard F. MacLehose, Research and practice in thrombosis and haemostasis. . 2021,第6期

机译：静脉血栓形成复发风险根据华法林对直接口服抗凝血剂进行二次预防静脉血栓形成
4. In Vivo Pharmacokinetic/pharmacodynamic analysis of firstgeneration anticoagulant rodenticide warfarin with Egyptian fruit bats (Rousettus aegyptiacus) for risk assessment of Bonin fruit bats (Pteropus pselaphon) [C] . Shouta M.M. Nakayama, Kosuke Manago, Kazuki Takeda 環境化学討論会要旨集 . 2019

机译：体内药代动力学/药效学分析埃及抗凝血剂的埃及抗凝血剂冠状动脉释放肽（Rousettus Aegyptiacus）的风险评估（Pteropus Pselaphon）
5. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism. [D] . Teschemaker, Anna R. 2011

机译：当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系：基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
6. Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism [O] . Catherine A Saint, Michelle R Castelli, Andrew J Crannage, 2017

机译：非维生素K口服抗凝剂或肠胃外药物加华法林治疗静脉血栓栓塞患者的住院时间比较
7. Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding [O] . Henry G Watson 2012

机译：在初始抗凝治疗后，阿司匹林长达2年，降低了静脉血栓栓塞复发的风险，而不会增加重大出血的风险

Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅